Atherectomy Devices Market Size (2024 - 2029)

The atherectomy devices market is anticipated to experience growth driven by the increasing preference for minimally invasive surgeries and continuous product development. The market's expansion is supported by the resurgence of cardiovascular procedures post-COVID-19, as restrictions ease and demand rises. Additionally, advancements in reimbursement and coverage reforms are expected to further enhance market growth. However, regulatory challenges may pose constraints on the market's expansion.

Market Size of Atherectomy Devices Industry

Atherectomy Devices Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.97 Billion
Market Size (2029) USD 1.41 Billion
CAGR (2024 - 2029) 7.69 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Atherectomy Devices Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Atherectomy Devices Market Analysis

The Atherectomy Devices Market size is estimated at USD 0.97 billion in 2024, and is expected to reach USD 1.41 billion by 2029, growing at a CAGR of 7.69% during the forecast period (2024-2029).

Like many other markets, the market was impacted by the COVID-19 pandemic. Various cardiovascular procedures and non-essential treatments were postponed. In March 2022, a research study was published in the Annals of Thoracic Surgery, which analyzed 717,103 adult cardiac surgery patients and more than 20 million COVID-19 patients stated that there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases. The Mid-Atlantic region was most affected by the first COVID-19 surge, with a 69.7% reduction in overall case volume and an 80.0% reduction in elective cases. In the Mid-Atlantic and New England regions, the observed-to-expected mortality for isolated coronary bypass increased as much as 1.48 times (148% increase) pre-COVID rates. After the first COVID-19 surge, nationwide cardiac surgical case volumes did not return to baseline, indicating a COVID-19-associated deficit in cardiac surgery patients. Atherectomy is a procedure used to clear out clogged heart arteries. The cardiac surgeries would also include atherectomy surgeries. Hence, the market was affected across the globe. Hence, with the easing of COVID-19 restrictions, worldwide, the market gained traction and is expected to bounce back to its full potential over the years.

The market for atherectomy devices is majorly driven by the increasing preference for minimally invasive surgeries. Research studies about the expansion of minimally invasive surgeries are another factor that drives the market growth. In October 2021, a research study was published in Elsevier Journal, stating that continuous progress in percutaneous coronary intervention (PCI) has inspired surgeons to reduce the invasiveness of surgical revascularization techniques, resulting in the development of minimally invasive cardiac surgery (MICS) procedures, which have widely expanded over the past couple of decades. The main goals of MICS are to avert any form of sternotomy, reduce postoperative blood product transfusion, shorten ventilation times, reduce intensive care and hospital stays, diminish postoperative pain, and accelerate the return to normal activities. Hence, due to such advantages of MICS, there will be growth in the adoption of such surgeries which would increase the market growth.

Additionally, continuous product development and commercialization are expected to propel the growth of the market. In November 2021, Royal Philips launched peripheral and coronary artery applications, including the Nexcimerlaser system in Orlando, United States. The new Philips Laser System - Nexcimer- offers plug-and-play simplicity for coronary and peripheral atherectomy and lead extraction procedures. It is the only system compatible with catheters with Level I clinical data for ISR atherectomy and that can also support lead extraction procedures (the removal of pacemaker or defibrillator leads around the heart).

In the current trend of healthcare, reimbursement, and coverage reform, payer and provider consolidation for escalating healthcare costs are essential for patients and their caregivers. Reimbursement and coverage reform enhances the chances of opting for the treatment if it is covered. Hence, increasing reimbursement would increase the market growth in the upcoming period. In 2022, the Centers for Medicare and Medicaid Services (CMS), has increased reimbursement for peripheral intravascular lithotripsy (IVL) procedures. Procedure including revascularization, endovascular, open or percutaneous, lower extremity arteries, except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel (s) (CPT code: C9764) will receive USD 10,258. Similarly, a procedure including revascularization, endovascular, open or percutaneous, lower extremity arteries, except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessels, (CPT code: C9765) will receive USD 16,402. Furthermore, processes including revascularization, endovascular, open or percutaneous, lower extremity arteries), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, including angioplasty within the same vessels, when performed (CPT code: C9767) will receive USD 16,402. Thus, all the above-mentioned factors are expected to boost the market over the forecast period.

However, the stringent regulatory scenarios may restrain the market growth over the forecast period.

Atherectomy Devices Industry Segmentation

As per the scope of the report, atherectomy is a minimally invasive endovascular procedure generally performed to remove atherosclerosis from blood vessels in the body. It is generally used to treat arteries. It can be used in veins and vascular bypass grafts as well. The atherectomy devices market is segmented by product (directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, and rotational atherectomy systems), application (peripheral vascular applications, cardiovascular applications, and neurovascular applications), end user (hospitals and surgical centers, ambulatory care centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Directional Atherectomy Systems
Orbital Atherectomy Systems
Photo-ablative (Laser) Atherectomy Systems
Rotational Atherectomy Systems
By Application
Peripheral Vascular Applications
Cardiovascular Applications
Neurovascular Applications
By End User
Hospitals and Surgical Centers
Ambulatory Care Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Atherectomy Devices Market Size Summary

The atherectomy devices market is poised for significant growth, driven by the increasing preference for minimally invasive surgeries and advancements in percutaneous coronary interventions. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a reduction in cardiac surgeries, including atherectomy procedures. However, as restrictions eased, the market began to recover, supported by the growing adoption of minimally invasive cardiac surgery procedures that offer benefits such as reduced postoperative pain and shorter recovery times. Continuous product development and innovation, such as the launch of new systems by companies like Royal Philips, are expected to further propel market growth. Additionally, favorable reimbursement policies, particularly in regions like North America, are anticipated to enhance the accessibility and adoption of atherectomy devices, contributing to the market's expansion.

The directional atherectomy segment is expected to witness substantial growth due to its cost-effectiveness and improved efficiency. Strategic initiatives by key market players, including product launches and regulatory approvals, are likely to bolster the market's competitive landscape. North America is projected to hold a significant market share, driven by the high prevalence of coronary artery diseases and the availability of reimbursement for atherectomy procedures. The region's dominance is further supported by a robust pipeline of FDA-approved devices and ongoing clinical trials. The market's competitive nature is underscored by the presence of major global players such as Abbott Laboratories, Boston Scientific, and Medtronic, who are actively expanding their product offerings to meet the rising demand for atherectomy devices.

Explore More

Atherectomy Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Continuous Product Development and Commercialization

      2. 1.2.2 Favourable Medical Reimbursement Scenario in Mature Markets

      3. 1.2.3 Growing Demand for Minimally Invasive Surgical Procedures

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Scenario

      2. 1.3.2 Lack of Well-trained Surgeons

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 Directional Atherectomy Systems

      2. 2.1.2 Orbital Atherectomy Systems

      3. 2.1.3 Photo-ablative (Laser) Atherectomy Systems

      4. 2.1.4 Rotational Atherectomy Systems

    2. 2.2 By Application

      1. 2.2.1 Peripheral Vascular Applications

      2. 2.2.2 Cardiovascular Applications

      3. 2.2.3 Neurovascular Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals and Surgical Centers

      2. 2.3.2 Ambulatory Care Centers

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Atherectomy Devices Market Size FAQs

The Atherectomy Devices Market size is expected to reach USD 0.97 billion in 2024 and grow at a CAGR of 7.69% to reach USD 1.41 billion by 2029.

In 2024, the Atherectomy Devices Market size is expected to reach USD 0.97 billion.

Atherectomy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)